Literature DB >> 23183356

Efficacy of a tyrothricin-containing wound gel in an abrasive wound model for superficial wounds.

W Wigger-Alberti1, M Stauss-Grabo, K Grigo, S Atiye, R Williams, H C Korting.   

Abstract

BACKGROUND: Topical preparations are a common treatment for superficial acute wounds, which at the least do not interfere with healing and ideally result in enhanced wound healing irrespective of microbial colonization.
OBJECTIVE: To examine the effects of a topical antimicrobial gel and its vehicle on the wound healing of standardized, superficial abrasions.
METHODS: Thirty-three healthy volunteers were enrolled in a double-blinded, randomized, intraindividual comparison study. Three standardized, superficial abrasions were induced on their forearms. A tyrothricin 0.1% gel (Tyrosur® gel; Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany) and its vehicle were randomly applied to two of the test areas, and one lesion remained untreated.
RESULTS: A significant improvement of wound healing was seen with both tyrothricin 0.1% gel and its corresponding vehicle in the clinical assessment. The mean area under the curve (AUC) of wound healing scores was the same for both preparations and the mean reepithelization scores were comparable at all test points over the entire 12 days. A lower mean AUC representing less reepithelization was found for the untreated test fields.
CONCLUSION: The use of tyrothricin 0.1% gel and its corresponding vehicle resulted in statistically significant improved wound healing with an earlier onset of healing in particular. Based on these results obtained using an abrasive wound model, it can be concluded that the addition of tyrothricin 0.1% to the gel vehicle did not interfere with the improved wound healing seen with the vehicle alone.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183356     DOI: 10.1159/000343907

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  7 in total

Review 1.  Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.

Authors:  Xu Yang; Ahmed E Yousef
Journal:  World J Microbiol Biotechnol       Date:  2018-03-29       Impact factor: 3.312

2.  Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.

Authors:  Y-H Chen; C-Y Liu; W-C Ko; C-H Liao; P-L Lu; C-H Huang; C-T Lu; Y-C Chuang; S-M Tsao; Y-S Chen; Y-C Liu; W-Y Chen; T-N Jang; H-C Lin; C-M Chen; Z-Y Shi; S-C Pan; J-L Yang; H-C Kung; C-E Liu; Y-J Cheng; J-W Liu; W Sun; L-S Wang; K-W Yu; P-C Chiang; M-H Lee; C-M Lee; G-J Hsu; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-18       Impact factor: 3.267

3.  Creating Robust Antimicrobial Materials with Sticky Tyrocidines.

Authors:  Wilma van Rensburg; Marina Rautenbach
Journal:  Antibiotics (Basel)       Date:  2022-01-28

4.  Screening for potential prophylactics targeting sporozoite motility through the skin.

Authors:  Ross G Douglas; Miriam Reinig; Matthew Neale; Friedrich Frischknecht
Journal:  Malar J       Date:  2018-08-31       Impact factor: 2.979

5.  Hydrogel or ointment? Comparison of five different galenics regarding tissue breathability and transepidermal water loss.

Authors:  Lars Rüther; Werner Voss
Journal:  Heliyon       Date:  2021-01-27

6.  The Influence of Cellulose-Type Formulants on Anti-Candida Activity of the Tyrocidines.

Authors:  Yasamin Masoudi; Wilma van Rensburg; Bernice Barnard-Jenkins; Marina Rautenbach
Journal:  Antibiotics (Basel)       Date:  2021-05-18

7.  The Multifaceted Antibacterial Mechanisms of the Pioneering Peptide Antibiotics Tyrocidine and Gramicidin S.

Authors:  Michaela Wenzel; Marina Rautenbach; J Arnold Vosloo; Tjalling Siersma; Christopher H M Aisenbrey; Ekaterina Zaitseva; Wikus E Laubscher; Wilma van Rensburg; Jan C Behrends; Burkhard Bechinger; Leendert W Hamoen
Journal:  MBio       Date:  2018-10-09       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.